Hiroki Yasui

1.3k total citations · 1 hit paper
33 papers, 1.0k citations indexed

About

Hiroki Yasui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hiroki Yasui has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Hiroki Yasui's work include Cancer Cells and Metastasis (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Hiroki Yasui is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Hiroki Yasui collaborates with scholars based in Japan, Finland and United Kingdom. Hiroki Yasui's co-authors include Yuichi Ohnishi, Osamu Taguchi, Esteban C. Gabazza, Masami Nozaki, Yukihiko Adachi, Tetsu Kobayashi, Ajay M. Shah, Hiroyuki Nakayama, Kinya Otsu and Takafumi Oka and has published in prestigious journals such as Nature Communications, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Hiroki Yasui

31 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation

2015 390 citations Tomokazu Murakawa, Osamu Yamaguchi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroki Yasui Japan	15	430	416	213	139	123	33	1.0k
James H. Finigan United States	17	307 0.7×	170 0.4×	333 1.6×	189 1.4×	102 0.8×	25	974
Jamila Khallou‐Laschet France	24	428 1.0×	321 0.8×	169 0.8×	71 0.5×	76 0.6×	38	1.7k
Joachim Pircher Germany	21	421 1.0×	132 0.3×	186 0.9×	200 1.4×	88 0.7×	41	1.2k
Suzhao Li United States	15	490 1.1×	203 0.5×	66 0.3×	100 0.7×	189 1.5×	32	1.4k
Shusaku Tsutsui Japan	23	390 0.9×	207 0.5×	625 2.9×	63 0.5×	81 0.7×	65	1.6k
Carla Jennewein Germany	17	532 1.2×	178 0.4×	117 0.5×	70 0.5×	122 1.0×	24	1.2k
Ekaterina K. Koltsova United States	16	523 1.2×	261 0.6×	234 1.1×	33 0.2×	88 0.7×	29	1.6k
Donglei Zhang China	21	404 0.9×	126 0.3×	301 1.4×	253 1.8×	86 0.7×	87	1.3k
Jay Tuttle United States	16	204 0.5×	271 0.7×	89 0.4×	137 1.0×	212 1.7×	40	1.1k
Berna Savaş Türkiye	18	197 0.5×	737 1.8×	99 0.5×	43 0.3×	73 0.6×	74	1.3k

Countries citing papers authored by Hiroki Yasui

Since Specialization

Citations

This map shows the geographic impact of Hiroki Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yasui more than expected).

Fields of papers citing papers by Hiroki Yasui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yasui. The network helps show where Hiroki Yasui may publish in the future.

Co-authorship network of co-authors of Hiroki Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Yasui. A scholar is included among the top collaborators of Hiroki Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Yasui. Hiroki Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yasui, Hiroki, et al.. (2025). Numerical Simulation of Unsteady Flow Past a Rotating Wells Turbine with Modified Blades. Journal of Ocean Engineering and Technology. 39(1). 73–81.

Nishii, Yoichi, Tadashi Sakaguchi, Yūta Suzuki, et al.. (2025). Suitability of Specimens from Pleural Dissemination of Non-Small Cell Lung Cancer for Genetic Testing Using Forceps and Cryobiopsy. Respiration. 104(11). 814–824.

Yasui, Hiroki, et al.. (2024). SPOT: In-depth Analysis of IoT Ransomware Attacks Using Bare Metal NAS Devices. Journal of Information Processing. 32(0). 23–34. 2 indexed citations

Nishii, Yoichi, Tadashi Sakaguchi, Yuki Nakamura, et al.. (2023). Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions. Scientific Reports. 13(1). 14724–14724. 3 indexed citations

Yasui, Hiroki, et al.. (2022). SPOT: Analyzing IoT Ransomware Attacks using Bare Metal NAS Devices. 16–23. 1 indexed citations

Yasui, Hiroki, Nobuaki Michihata, Hiroki Matsui, et al.. (2021). Association between ambulance use and hospitalization costs among heart failure patients. Heart and Vessels. 36(5). 654–658. 5 indexed citations

Ohnishi, Yuichi, Hiroki Yasui, Masami Nozaki, & Masahiro Nakajima. (2017). Molecularly-targeted therapy for the oral cancer stem cells. Japanese Dental Science Review. 54(2). 88–103. 17 indexed citations

Yasui, Hiroki, Yuichi Ohnishi, Masahiro Nakajima, & Masami Nozaki. (2017). Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation. Oncology Reports. 37(6). 3674–3680. 17 indexed citations

Ishiki, Hiroto, Aya Watanabe, Chie Watanabe, et al.. (2017). Prevalence of myofascial pain syndrome in patients with incurable cancer. Journal of Bodywork and Movement Therapies. 22(2). 328–332. 12 indexed citations

10.

Ohnishi, Yuichi, Hiroki Yasui, Kenji Kakudo, & Masami Nozaki. (2016). Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells. Oncology Letters. 13(2). 930–936. 39 indexed citations

11.

Okamoto, Tomoko, et al.. (2016). Clinicostatistical observation of odontogenic tumors based on the WHO histological classification of 2005. Journal of Osaka Dental University. 50(2). 103–109. 1 indexed citations

12.

Murakawa, Tomokazu, Osamu Yamaguchi, Ayako Hashimoto, et al.. (2015). Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nature Communications. 6(1). 7527–7527. 390 indexed citations breakdown →

13.

Ohnishi, Yuichi, Hiroki Yasui, Kenji Kakudo, & Masami Nozaki. (2015). Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway. International Journal of Oncology. 47(6). 2165–2172. 14 indexed citations

14.

Ohnishi, Yuichi, Masahiro Watanabe, Hiroki Yasui, & Kenji Kakudo. (2014). Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines. Oncology Letters. 7(5). 1439–1442. 4 indexed citations

15.

Takao, Motoshi, et al.. (2003). A Surgical Case of Solitary Extramedullary Plasmacytoma Occurring in the Mediastinum. Haigan. 43(6). 721–724. 1 indexed citations

16.

Shimizu, Shino, Esteban C. Gabazza, Osamu Taguchi, et al.. (2003). Activated Protein C Inhibits the Expression of Platelet-derived Growth Factor in the Lung. American Journal of Respiratory and Critical Care Medicine. 167(10). 1416–1426. 63 indexed citations

17.

Yasui, Hiroki, Esteban C. Gabazza, Shigenori Tamaki, et al.. (2001). Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse. American Journal of Respiratory and Critical Care Medicine. 163(7). 1660–1668. 116 indexed citations

18.

Kobayashi, Tetsu, Esteban C. Gabazza, Shino Shimizu, et al.. (2001). Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice. American Journal of Respiratory and Critical Care Medicine. 163(7). 1676–1682. 10 indexed citations

19.

Kobayashi, Tetsu, Esteban C. Gabazza, Osamu Taguchi, et al.. (1999). Type I collagen metabolites as tumor markers in patients with lung carcinoma. Cancer. 85(9). 1951–1957. 32 indexed citations

20.

Kobayashi, Hiroyasu, Esteban C. Gabazza, Osamu Taguchi, et al.. (1998). Protein C Anticoagulant System in Patients with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 157(6). 1850–1854. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact